SNYNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SNYNF
Sanofi
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026
$39.57−1.04 (-2.56%)
Close on Oct 19, 2026
Share price
−$11.05 (−21.83%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Ex-dividend
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- €7.81B
- EPS, diluted
- 6.37 EUR
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Twelve years at a glance
Fiscal years 2014 to 2025, EUR
Gross profit
€33.67B+8.3% YoY
Operating income
€6.34B-12.5% YoY
Net income
€7.81B+40.5% YoY
EPS, diluted
6.37 EUR+43.8% YoY
Reported period